1100023I saic - preclin services - DEV of biopharmaceutical products - task BP-011 preclinical development of humanized anti-ricin monoclonal antibody - product development planning for cgmp…

Ended Awarded Last action

Contract number
HHSN27200011
Awardee
Awarding agency
Obligated
$33,235

Award facts

Contract value 100% obligated
$33,235.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Frederick, MD 21703, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 · DE-obligation of expiring FY'14 funds -$1,126
Funding Only Action P00001 -$17,864
Original award $52,225

Description

1100023I saic - preclin services - DEV of biopharmaceutical products - task BP-011 preclinical development of humanized anti-ricin monoclonal antibody - product development planning for cgmp manufacture - biod can 8470038 $52,225

Quick answers

Who was awarded contract HHSN27200011?

HHSN27200011 was awarded to Leidos, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 18, 2014.

How much is contract HHSN27200011 worth?

The government has obligated $33,235 on HHSN27200011.

Is contract HHSN27200011 an order under another contract?

Yes. HHSN27200011 is a delivery order under HHSN272201100023I, an indefinite delivery contract.

Was contract HHSN27200011 competed?

The extent of competition for HHSN27200011 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award